NCT04668625View on ClinicalTrials.gov

Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures

NACompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

December 20, 2020

Study Completion Date

January 8, 2021

Conditions

COVID-19 (SARS-CoV-2)

Interventions

BEHAVIORAL

Participate in a massive musical event

Trial Locations (1)

08916

Germans Trias i Pujol Hospital, Badalona

All Listed Sponsors

collaborator

Dr. Bonaventura Clotet Sala

UNKNOWN

collaborator

Dr. Josep Mª LLibre Codina

UNKNOWN

collaborator

Dr. Boris Revollo Barriga

UNKNOWN

collaborator

Dra. Lidia Ruiz Tabuenca

UNKNOWN

collaborator

Dr. Ignacio Blanco Guillermo

UNKNOWN

collaborator

Dra. Andrea Alemany Ortiz

UNKNOWN

collaborator

Dr. Roger Paredes Deiros

UNKNOWN

lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT04668625 - Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures | Biotech Hunter | Biotech Hunter